IEQ CAPITAL, LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 116 filers reported holding OCULAR THERAPEUTIX INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.

Quarter-by-quarter ownership
IEQ CAPITAL, LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$265,421
-39.1%
84,5290.0%0.01%
-44.4%
Q2 2023$436,170
-2.1%
84,5290.0%0.01%
-10.0%
Q1 2023$445,468
+13.6%
84,529
-39.4%
0.01%
-9.1%
Q4 2022$392,076
-66.7%
139,529
-50.9%
0.01%
-65.6%
Q3 2022$1,178,000
+3.2%
283,9330.0%0.03%
-8.6%
Q2 2022$1,141,000
-43.5%
283,933
-30.4%
0.04%
-27.1%
Q1 2022$2,019,000
-29.0%
407,9330.0%0.05%
-27.3%
Q4 2021$2,843,000
-54.8%
407,933
-35.1%
0.07%
-60.5%
Q3 2021$6,289,000
-29.5%
628,982
+0.0%
0.17%
-36.3%
Q2 2021$8,918,000
-13.6%
628,9330.0%0.26%
-38.5%
Q1 2021$10,321,000
-20.7%
628,9330.0%0.43%
-26.4%
Q4 2020$13,019,000
+151.9%
628,933
-7.4%
0.58%
+108.3%
Q3 2020$5,169,000
-8.6%
679,2330.0%0.28%
-24.3%
Q2 2020$5,658,000
+346.6%
679,233
+165.3%
0.37%
+259.8%
Q1 2020$1,267,000
+25.3%
256,0450.0%0.10%
+14.6%
Q4 2019$1,011,000256,0450.09%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q4 2022
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$31,590100.00%
Opaleye Management Inc. 5,780,000$29,824,8007.13%
DELTEC ASSET MANAGEMENT LLC 1,974,797$10,189,9532.23%
Lynwood Capital Management Inc. 262,500$1,354,5001.72%
Endurant Capital Management LP 368,438$1,901,1401.66%
Knoll Capital Management, LLC 200,000$1,032,0001.25%
Knoll Capital Management, LLC 95,800$814,3000.99%
SECTORAL ASSET MANAGEMENT INC 802,680$4,141,8290.69%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,977$1,553,0410.22%
Cormorant Asset Management, LP 645,000$3,328,2000.19%
View complete list of OCULAR THERAPEUTIX INC shareholders